OGN

NYSE · Pharmaceuticals

Organon & Co

Small-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$6.03

-0.24 (-3.83%)

As of Mar 22, 10:03 PM ET ·

Analyst Consensus

Strong Sell

Analysts

High

Coverage

Buy 1 6%

Hold 6 38%

Sell 9 56%

Price Target

Analyst Price Target +1,399.2% upside

Low Target $73.92

Average Target $90.40

High Target $125.40

Current Price $6.03

Current
$6.03

Target
$90.40

$73.92 $90.40 avg $125.40

Scenario Analysis

Bear Case

$73.92

1,125.9%

Low target

Base Case

$90.40

+1,399.2%

Avg target

Bull Case

$125.40

+1,979.6%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$15.88

-62.0% from high

52-Week Low

$6.16

+-2.0% from low

50-Day SMA

$7.87

-23.4% vs SMA

200-Day SMA

$8.85

-31.9% vs SMA

RSI (14)

32.1

Neutral

Target vs 52W High

$90.40

+469.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+47.3%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+27.3%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+36.9%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+25.7%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+204.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+81.0%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-20.4%
VTRS Viatris Inc	Buy	18	67%	$122.82	+819.3%